CLDN18.2-Specific CAR T-Cell Therapy Prolongs PFS in Patients with Previously Treated Advanced Gastric or Gastro-oesophageal Junction Cancer By Ogkologos - August 14, 2025 437 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the CT041-ST-01 study Source RELATED ARTICLESMORE FROM AUTHOR Patient Guide in Testicular Cancer Now Available Also in Italian Adding 177Lu-PNT2002 to SBRT Significantly Improves PFS in Patients with Oligorecurrent Hormone-Sensitive Prostate Cancer A Short-Course Dose Escalation Strategy Could Improve Ability to Reach Target Dose of Adjuvant Abemaciclib in High-Risk Early-Stage HR-positive, HER2-negative Breast Cancer MOST POPULAR ¿Las gammagrafías óseas muestran el cáncer? April 28, 2021 Man Becomes Nervous About How Cop Acts During Ticket, Then He... June 6, 2019 How Pelvic Floor Therapy Can Help People With Prostate Cancer and... December 13, 2022 A Remarkable Group of Patients with Haematological Disorders with No or... December 15, 2021 Load more HOT NEWS Navigating Life During and After Cancer As a Young Adult: A... EMA Recommends Granting a Conditional Marketing Authorisation for Autologous Anti-CD19-Transduced CD3+... Creating a shared vision to detect cancer earlier 3 ways we’re helping teenagers and young adults with cancer
